Clinical Trial Update: Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy [NA]

View source ↗

Summary

Clinical trial update describing a comparative study in HIV-negative patients with talaromycosis assessing voriconazole versus sequential amphotericin B followe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Talaromycosis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• Itraconazole (Sporanox) (Itraconazole)
• Voriconazole (Vfend) (voriconazole)

Snippet

Sponsor: Guangxi Medical University | Conditions: Talaromyces in Human Immunodeficiency Virus Negative, To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy | NA | Status: UNKNOWN